220 related articles for article (PubMed ID: 18854728)
1. Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients.
Cantor LB; WuDunn D; Catoira-Boyle Y; Yung CW
J Glaucoma; 2008; 17(7):529-34. PubMed ID: 18854728
[TBL] [Abstract][Full Text] [Related]
2. Formulation effects on ocular absorption of brimonidine in rabbit eyes.
Acheampong AA; Small D; Baumgarten V; Welty D; Tang-Liu D
J Ocul Pharmacol Ther; 2002 Aug; 18(4):325-37. PubMed ID: 12222763
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
4. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.
Acheampong AA; Shackleton M; Tang-Liu DD
Drug Metab Dispos; 1995 Jul; 23(7):708-12. PubMed ID: 7587958
[TBL] [Abstract][Full Text] [Related]
5. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
Kim DH; Stark WJ; O'Brien TP; Dick JD
Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Bucci FA; Waterbury LD
J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure.
Tzovolou DN; Lamari F; Mela EK; Gartaganis SP; Karamanos NK
Biomed Chromatogr; 2000 Aug; 14(5):301-5. PubMed ID: 10960828
[TBL] [Abstract][Full Text] [Related]
9. Flomoxef sodium and levofloxacin concentrations in aqueous humor.
Mizuki N; Watanabe Y; Miyamoto M; Iijima Y; Takiyama N; Ito Y; Ito N; Nishida T; Iwata S; Endo Y; Ito D
Ocul Immunol Inflamm; 2005; 13(2-3):229-34. PubMed ID: 16019684
[TBL] [Abstract][Full Text] [Related]
10. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
Yoshida J; Kim A; Pratzer KA; Stark WJ
J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
[TBL] [Abstract][Full Text] [Related]
11. Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits.
Dong JQ; Babusis DM; Welty DF; Acheampong AA; Tang-Liu D; Whitcup SM
J Ocul Pharmacol Ther; 2004 Aug; 20(4):285-92. PubMed ID: 15321023
[TBL] [Abstract][Full Text] [Related]
12. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
[TBL] [Abstract][Full Text] [Related]
13. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
Bucci FA
Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
[TBL] [Abstract][Full Text] [Related]
14. Determination of drug concentration in aqueous humor of cataract patients administered gatifloxacin ophthalmic gel.
Liu X; Wang NL; Wang YL; Ma C; Ma L; Gao LX; Huang YX; Xiong SH; Wang K
Chin Med J (Engl); 2010 Aug; 123(15):2105-10. PubMed ID: 20819550
[TBL] [Abstract][Full Text] [Related]
15. Development of an HPLC method for determining the alpha 2-adrenergic receptor agonist brimonidine in blood serum and aqueous humor of the eye.
Karamanos NK; Lamari F; Katsimpris J; Gartaganis S
Biomed Chromatogr; 1999 Feb; 13(1):86-8. PubMed ID: 10191952
[TBL] [Abstract][Full Text] [Related]
16. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
[TBL] [Abstract][Full Text] [Related]
17. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.
Cantor LB; Hoop J; Wudunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
Br J Ophthalmol; 2007 May; 91(5):629-32. PubMed ID: 17135335
[TBL] [Abstract][Full Text] [Related]
18. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
[TBL] [Abstract][Full Text] [Related]
19. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
Kesler A; Shemesh G; Rothkoff L; Lazar M
J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.
Schmitz K; Banditt P; Motschmann M; Meyer FP; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1621-4. PubMed ID: 10359348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
